New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
08:50 EDTINSMInsmed breakthrough designation a 'game changer,' says Piper Jaffray
Piper Jaffray views the breakthrough designation for Arikayce for the treatment of nontuberculous mycobacterial as a "game changer" for Insmed. Piper expects shares to move sharply higher today and says the news brings the company "another important step closer toward approval." It reiterates an Overweight rating on Insmed with a $51 price target. The stock is up 27% in pre-open trading to $15.82.
News For INSM From The Last 14 Days
Check below for free stories on INSM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 8, 2014
10:42 EDTINSMOptions with decreasing implied volatility
Options with decreasing implied volatility: KERX CONN CIEN INSM FNSR PAY PVH SWY
07:18 EDTINSMRodman & Renshaw to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use